XOMA Royalty Corporation Share Price Nasdaq
Equities
XOMA.O
US98419J4040
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.92 USD | -0.91% | -0.48% | -0.80% |
10/07 | XOMA Corporation will Change its Name to XOMA Royalty Corporation | CI |
09/07 | Xoma Changes Name to Xoma Royalty | MT |
Sales 2024 * | 21M 1.75B | Sales 2025 * | 26.93M 2.25B | Capitalization | 314M 26.24B |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.84B | Net income 2025 * | -15M -1.25B | EV / Sales 2024 * | 15 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 11.7 x |
P/E ratio 2024 * |
-14.3
x | P/E ratio 2025 * |
-20.5
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.47% |
1 day | -0.91% | ||
1 week | -0.48% | ||
Current month | -1.74% | ||
1 month | -0.97% | ||
3 months | -0.32% | ||
6 months | +3.83% | ||
Current year | -0.80% |
Managers | Title | Age | Since |
---|---|---|---|
Owen Hughes
CEO | Chief Executive Officer | 49 | 01/23/01 |
Thomas Burns
DFI | Director of Finance/CFO | 50 | 14/06/14 |
Bradley Sitko
CIO | Chief Investment Officer | 43 | 03/23/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heather Franklin
BRD | Director/Board Member | 58 | 06/21/06 |
Chairman | 68 | 26/10/26 | |
Joseph Limber
BRD | Director/Board Member | 71 | 12/12/12 |
Date | Price | Change | Volume |
---|---|---|---|
16/24/16 | 24.92 | -0.91% | 5,399 |
15/24/15 | 25.15 | -0.51% | 1,750 |
12/24/12 | 25.28 | +0.72% | 672 |
11/24/11 | 25.1 | -0.63% | 1,848 |
10/24/10 | 25.26 | +0.87% | 2,244 |
Delayed Quote Nasdaq, July 17, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- XOMA Stock
- XOMA.O Stock